Announcement • Mar 24
Bayview Acquisition Corp Receives Notice of Hearing Before the Panel Scheduled for March 31, 2026 As previously disclosed, on February 19, 2026, Bayview Acquisition Corp, a Cayman Islands exempted corporation (the Company) received a written notice from the Listing Qualifications Department (the Staff) of The Nasdaq Stock Market LLC (Nasdaq) notifying the Company that the Staff had determined to delist the Company's securities from Nasdaq. On December 16, 2025, the Company submitted an application to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market (the Transfer Application). The Company believes that, upon approval of the Transfer Application, it will be better positioned to cure the market value of listed securities deficiency under Nasdaq Listing Rule 5450(b)(2)(A) and the minimum public holders deficiency under Nasdaq Listing Rule 5450(a)(2), each as previously disclosed. However, there can be no assurance that the Transfer Application will be approved. In connection with the delist notice received on February 19, 2026, the Company timely requested a hearing before a Nasdaq Hearings Panel (the Panel) to appeal the determination. On February 24, 2026, the Company received formal notice that a hearing before the Panel has been scheduled for March 31, 2026 at 11:00 a.m. Eastern Time (the Hearing). The Hearing will be conducted via video conference. On March 19, 2026, the Company received a written notice from the Staff notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(B) (the PHS Rule), which requires the Company to maintain a minimum of 1,100,000 publicly held shares for continued listing. Pursuant to Nasdaq Listing Rule 5810(d), the Company will present its views with respect to the PHS Rule deficiency at the Hearing. Although the Company will use all reasonable efforts to regain compliance with each of the Nasdaq listing rules, there can be no assurance that the Company will be able to regain compliance with those rules or will otherwise be in compliance with other Nasdaq listing criteria. There can also be no assurance that the appeal in connection with the Hearing will be successful. Announcement • Mar 16
Bayview Acquisition Corp, Annual General Meeting, Apr 10, 2026 Bayview Acquisition Corp, Annual General Meeting, Apr 10, 2026. Location: offices of winston & strawn llp at 800 capitol, street, suite 2400, texas, houston, United States Announcement • Feb 23
Bayview Acquisition Corp Receives Notice of Nasdaq Delisting Due to Non-Compliance with Listing Rules As previously disclosed in Bayview Acquisition Corp’s, a Cayman Islands exempted corporation Current Report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2025, the Company received a written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) (“the MVLS Rule”), which requires the Company to maintain a minimum Market Value of Listed Securities of $50.0 million. On February 19, 2026, the Company received a written notice (the “Notice”) from the Staff notifying the Company that the Company has not regained compliance with the MVLS Rule, and also that the Company is not in compliance with Nasdaq Listing Rules 5450(b)(2)(C), 5810(c)(3)(D), 5810(b), and 5505 (collectively, the “MVPHS Rules”), which require the Company to maintain a minimum Market Value of Publicly Held Shares of $15.0 million, and Nasdaq Listing Rule 5620(a) (the “Annual Meeting Rule”), which requires the Company to hold an annual meeting of shareholders within twelve months of the end of its fiscal year. Accordingly, the Staff determined that the Company’s securities will be delisted from The Nasdaq Global Market unless the Company requests an appeal of this determination by February 26, 2026. The Notice states that if the Company does not appeal the Staff’s delisting determination by that date, trading of the Company’s common stock will be suspended at the opening of business on March 2, 2026, and a Form 25-NSE will be filed with the SEC, which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. The Company intends to appeal the Staff’s delisting determination to a Nasdaq Hearings Panel (the “Panel”) by February 26, 2026, and a hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. However, there can be no assurance that such appeal would be successful. 
